RO60 Polyclonal Antibody

Rabbit Anti-RO60 Polyclonal Antibody

Product Specifications

Background

TROVE2 (TROVE Domain Family Member 2) is a Protein Coding gene. Diseases associated with TROVE2 include sjogren's syndrome and congenital heart block. Among its related pathways are Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3. GO annotations related to this gene include RNA binding and U2 snRNA binding.

CAS Number

9007-83-4

Product Name Alternative

TROVE2; RO60; SSA2; 60 kDa SS-A/Ro ribonucleoprotein; 60 kDa Ro protein; 60 kDa ribonucleoprotein Ro; RoRNP; Ro 60 kDa autoantigen; Sjoegren syndrome antigen A2; Sjoegren syndrome type A antigen; SS-A; TROVE domain family member 2

Gene ID

6738

Accession Number

P10155

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human RO60 at AA range: 280-360

Clonality

Polyclonal

Tag

60 kDa SS-A

Applications

WB, IHC

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

70kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

RO60 Polyclonal Antibody detects endogenous levels of RO60 protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; IHC 1:50-300